CD44 and breast cancer: Consistent with this finding, recent studies showed that inhibition of the Hh pathway attenuates stem cell phenotypes such as CD44+/CD24− cells and sphere forming capacity in breast cancer cell lines (Yang et al., 2016; Koike et al., 2017).